Transplant of SARS-CoV-2–infected Living Donor Liver: Case Report

Given the high community prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), transplant programs will encounter SARS-CoV-2 infections in living donors or recipients in the perioperative period. There is limited data on SARS-CoV-2 viremia and organotropism beyond the respirato...

Full description

Saved in:
Bibliographic Details
Published in:Transplantation direct 2021-07, Vol.7 (8), p.e721-e721
Main Authors: Nguyen, Michelle C., Lee, Eliza J., Avery, Robin K., Dioverti-Prono, M. Veronica, Shoham, Shmuel, Tobian, Aaron A. R., Bloch, Evan M., Gurakar, Ahmet, Rizkalla, Nicole A., Cameron, Andrew M., King, Elizabeth A., Ottmann, Shane, Garonzik-Wang, Jacqueline M., Wesson, Russel N., Philosophe, Benjamin
Format: Article
Language:English
Subjects:
Liver Transplantation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Given the high community prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), transplant programs will encounter SARS-CoV-2 infections in living donors or recipients in the perioperative period. There is limited data on SARS-CoV-2 viremia and organotropism beyond the respiratory tract to inform the risk of transplant transmission of SARS-CoV-2. We report a case of a living donor liver transplant recipient who received a right lobe graft from a living donor with symptomatic PCR-confirmed SARS-CoV-2 infection 3 d following donation. The donor was successfully treated with remdesivir, dexamethasone, and coronavirus disease 2019 (COVID-19) convalescent plasma. No viral transmission was identified, and both donor and recipient had excellent postoperative outcomes.
ISSN:2373-8731
2373-8731
DOI:10.1097/TXD.0000000000001178